Detection of Plasma EGFR Mutations in NSCLC Patients with a Validated ddPCR Lung cfDNA Assay
Qiaomei Guo(Shanghai Jiao Tong University), Jiatao Lou(Shanghai First People's Hospital), Yameng Sun(Renji Hospital), Sheng Ni(Hong Kong University of Science and Technology), Lin Wang(Shanghai Jiao Tong University), Yunhua Xu(Shanghai Chest Hospital), Xiaomeng Hu(Shanghai Jiao Tong University), Mingna Zhao(Shanghai Chest Hospital), Wenjun Yu(Shanghai Jiao Tong University), Lihua Qiao(Shanghai Jiao Tong University)
Cited by 38
Related Papers
New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment
|Hepatology|2016|156
Plasma Levels of Heat Shock Protein 90 Alpha Associated with Lung Cancer Development and Treatment Responses
|Clinical Cancer Research|2014|115
Persistent Low Level of Hepatitis B Virus Promotes Fibrosis Progression During Therapy
|Clinical Gastroenterology and Hepatology|2020|115
The vision of point-of-care PCR tests for the COVID-19 pandemic and beyond
|TrAC Trends in Analytical Chemistry|2020|97
Hepatocellular Carcinoma Prediction Models in Chronic Hepatitis B: A Systematic Review of 14 Models and External Validation
|Clinical Gastroenterology and Hepatology|2021|64